Eligible patients were aged 40 years with a diagnosis of IPF within 5 years before randomization who had undergone a chest high-resolution computed tomography ( HRCT ) scan within 1-year before screening , and who had a forced vital capacity ( FVC ) of 50 % predicted and a diffusing capacity for carbon monoxide of 30-79 % predicted .